2018
DOI: 10.1021/acschemneuro.8b00053
|View full text |Cite
|
Sign up to set email alerts
|

Poly(ADP-ribose) Polymerase in Neurodegeneration: Radiosynthesis and Radioligand Binding in ARC-SWE tg Mice

Abstract: We report the synthesis, radiosynthesis, and characterization of a radioligand for poly(ADP-ribose) polymerase (PARP). PARP is of central importance in cell homeostasis, neuroplasticity, and neurodegeneration in the brain. A radiolabeled PARP inhibitor was developed and used for autoradiographic quantification of PARP protein concentration in wild-type and transgenic rodent brains ex vivo in high resolution. The binding of [H]rucaparib was found to be confined to PARP-expressing domains, for example, cerebella… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 33 publications
0
12
0
Order By: Relevance
“…Meanwhile, over-activated PARP-1 will increase its interaction with transcription regulators such as nuclear receptors, sirtuins, and other metabolic transcription factors. Further, it will also lead to the impairment of mitochondrial function that seems to be an early and critically important event in the pathogenesis of AD 9 , 11 . Although the role of PARP-1 in human AD is not fully elucidated and many mechanisms are under investigations, accumulating evidences suggest that PARP-1 inhibitors are viable to neuroprotection and PARP-1 has emerged as a potential therapeutic target for AD 12 , 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, over-activated PARP-1 will increase its interaction with transcription regulators such as nuclear receptors, sirtuins, and other metabolic transcription factors. Further, it will also lead to the impairment of mitochondrial function that seems to be an early and critically important event in the pathogenesis of AD 9 , 11 . Although the role of PARP-1 in human AD is not fully elucidated and many mechanisms are under investigations, accumulating evidences suggest that PARP-1 inhibitors are viable to neuroprotection and PARP-1 has emerged as a potential therapeutic target for AD 12 , 13 .…”
Section: Introductionmentioning
confidence: 99%
“…A further application of an Uhle's ketone derivative was the synthesis and radiosynthesis of [ 3 H]rucaparib (125) (Scheme 24). 22 Rucaparib (123) is a selective poly(ADPribose)polymerase (PARP) inhibitor; in particular, it is a PARP-1 inhibitor that is used as an anticancer agent. 45 It is approved in the United States and in Europe as a third-line treatment for BRCA-mutated ovarian cancer.…”
Section: Short Review Synthesismentioning
confidence: 99%
“…In 2018, Cao and co-workers 15 reported the synthesis of racemic 4-amino-Uhle's ketone derivatives 25 and 26 (Scheme 4) using methodology previously developed by the Bernardi group 16 three years earlier. This approach consisted of a Brønsted acid catalyzed domino Friedel-Crafts/Henry reaction between commercially available indole-4-carbaldehyde (22) and nitroethylene. The tricyclic alcohol 23 was obtained in 66% yield, using (±)-1,1′-binaphthyl-2,2′-diyl hydrogen phosphate as the phosphoric acid (PA).…”
Section: Short Review Synthesismentioning
confidence: 99%
See 2 more Smart Citations